Download Free Medical Antiarrhythmic Drugs PowerPoint Presentation

Antiarrhythmic Drugs PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical presentation on Arrhythmia, which is titled "Antiarrhythmic Drugs", to know how antiarrhythmic drugs work.

Tags : Arrhythmia, Antiarrhythmic Drugs

Published on : Jun 02, 2021 | Views : 2063 | Downloads : 14

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

Antiarrhythmic Drugs Or Doing Drugs for Your Heartbeat
Slide 2-

Background Recall: to function efficiently, heart needs to contract sequentially (atria, then ventricles) and in synchronicity Relaxation must occur between contractions (not true for other types of muscle [exhibit tetany  contract and hold contraction for certain length of time]) Coordination of heartbeat is a result of a complex, coordinated sequence of changes in membrane potentials and electrical discharges in various heart tissues
Slide 3-

Arrhythmia Heart condition where disturbances in Pacemaker impulse formation Contraction impulse conduction Combination of the two Results in rate and/or timing of contraction of heart muscle that is insufficient to maintain normal cardiac output (CO) To understand how antiarrhythmic drugs work, need to understand electrophysiology of normal contraction of heart
Slide 4-

Normal heartbeat and atrial arrhythmia Normal rhythm Atrial arrhythmia AV septum
Slide 5-

Ventricular Arrhythmia Ventricular arrhythmias are common in most people and are usually not a problem but… VA’s are most common cause of sudden death Majority of sudden death occurs in people with neither a previously known heart disease nor history of VA’s Medications which decrease incidence of VA’s do not decrease (and may increase) the risk of sudden death treatment may be worse then the disease!
Slide 6-

Electrophysiology - resting potential A transmembrane electrical gradient (potential) is maintained, with the interior of the cell negative with respect to outside the cell Caused by unequal distribution of ions inside vs. outside cell Na+ higher outside than inside cell Ca+ much higher “ “ “ “ K+ higher inside cell than outside Maintenance by ion selective channels, active pumps and exchangers
Slide 7-

ECG (EKG) showing wave segments Contraction of atria Contraction of ventricles Repolarization of ventricles
Slide 8-

Cardiac Action Potential Divided into five phases (0,1,2,3,4) Phase 4 - resting phase (resting membrane potential) Phase cardiac cells remain in until stimulated Associated with diastole portion of heart cycle Addition of current into cardiac muscle (stimulation) causes Phase 0 – opening of fast Na channels and rapid depolarization Drives Na+ into cell (inward current), changing membrane potential Transient outward current due to movement of Cl- and K+ Phase 1 – initial rapid repolarization Closure of the fast Na+ channels Phase 0 and 1 together correspond to the R and S waves of the ECG
Slide 9-

Cardiac Na+ channels
Slide 10-

Cardiac Action Potential (con’t) Phase 2 - plateau phase sustained by the balance between the inward movement of Ca+ and outward movement of K + Has a long duration compared to other nerve and muscle tissue Normally blocks any premature stimulator signals (other muscle tissue can accept additional stimulation and increase contractility in a summation effect) Corresponds to ST segment of the ECG. Phase 3 – repolarization K+ channels remain open, Allows K+ to build up outside the cell, causing the cell to repolarize K + channels finally close when membrane potential reaches certain level Corresponds to T wave on the ECG
Slide 11-

Differences between nonpacemaker and pacemaker cell action potentials PCs - Slow, continuous depolarization during rest Continuously moves potential towards threshold for a new action potential (called a phase 4 depolarization)
Slide 12-

Mechanisms of Cardiac Arrhythmias Result from disorders of impulse formation, conduction, or both Causes of arrhythmias Cardiac ischemia Excessive discharge or sensitivity to autonomic transmitters Exposure to toxic substances Unknown etiology
Slide 13-

Disorders of impulse formation No signal from the pacemaker site Development of an ectopic pacemaker May arise from conduction cells (most are capable of spontaneous activity) Usually under control of SA node  if it slows down too much conduction cells could become dominant Often a result of other injury (ischemia, hypoxia) Development of oscillatory afterdepolariztions Can initiate spontaneous activity in nonpacemaker tissue May be result of drugs (digitalis, norepinephrine) used to treat other cardiopathologies
Slide 14-

Afterdepolarizations
Slide 15-

Disorders of impulse conduction May result in Bradycardia (if have AV block) Tachycardia (if reentrant circuit occurs) Reentrant circuit
Slide 16-

Antiarrhythmic drugs Biggest problem – antiarrhythmics can cause arrhythmia! Example: Treatment of a non-life threatening tachycardia may cause fatal ventricular arrhythmia Must be vigilant in determining dosing, blood levels, and in follow-up when prescribing antiarrhythmics
Slide 17-

Therapeutic overview Na+ channel blockade β-adrenergic receptor blockade Prolong repolarization Ca2+ channel blockade Adenosine Digitalis glycosides
Slide 18-

Classification of antiarrhythmics (based on mechanisms of action) Class I – blocker’s of fast Na+ channels Subclass IA Cause moderate Phase 0 depression Prolong repolarization Increased duration of action potential Includes Quinidine – 1st antiarrhythmic used, treat both atrial and ventricular arrhythmias, increases refractory period Procainamide - increases refractory period but side effects Disopyramide – extended duration of action, used only for treating ventricular arrthymias
Slide 19-

Classification of antiarrhythmics (based on mechanisms of action) Subclass IB Weak Phase 0 depression Shortened depolarization Decreased action potential duration Includes Lidocane (also acts as local anesthetic) – blocks Na+ channels mostly in ventricular cells, also good for digitalis-associated arrhythmias Mexiletine - oral lidocaine derivative, similar activity Phenytoin – anticonvulsant that also works as antiarrhythmic similar to lidocane
Slide 20-

Classification of antiarrhythmics (based on mechanisms of action) Subclass IC Strong Phase 0 depression No effect of depolarization No effect on action potential duration Includes Flecainide (initially developed as a local anesthetic) Slows conduction in all parts of heart, Also inhibits abnormal automaticity Propafenone Also slows conduction Weak β – blocker Also some Ca2+ channel blockade
Slide 21-

Classification of antiarrhythmics (based on mechanisms of action) Class II – β–adrenergic blockers Based on two major actions 1) blockade of myocardial β–adrenergic receptors 2) Direct membrane-stabilizing effects related to Na+ channel blockade Includes Propranolol causes both myocardial β–adrenergic blockade and membrane-stabilizing effects Slows SA node and ectopic pacemaking Can block arrhythmias induced by exercise or apprehension Other β–adrenergic blockers have similar therapeutic effect Metoprolol Nadolol Atenolol Acebutolol Pindolol Stalol Timolol Esmolol
Slide 22-

Classification of antiarrhythmics (based on mechanisms of action) Class III – K+ channel blockers Developed because some patients negatively sensitive to Na channel blockers (they died!) Cause delay in repolarization and prolonged refractory period Includes Amiodarone – prolongs action potential by delaying K+ efflux but many other effects characteristic of other classes Ibutilide – slows inward movement of Na+ in addition to delaying K + influx. Bretylium – first developed to treat hypertension but found to also suppress ventricular fibrillation associated with myocardial infarction Dofetilide - prolongs action potential by delaying K+ efflux with no other effects
Slide 23-

Classification of antiarrhythmics (based on mechanisms of action) Class IV – Ca2+ channel blockers slow rate of AV-conduction in patients with atrial fibrillation Includes Verapamil – blocks Na+ channels in addition to Ca2+; also slows SA node in tachycardia Diltiazem
Slide 24-

Pacemakers Surgical implantation of electrical leads attached to a pulse generator Over 175,000 implanted per year Leads are inserted via subclavicle vein and advanced to the chambers on the vena cava (right) side of the heart Two leads used, one for right atrium, other for right ventricle Pulse generator containing microcircuitry and battery are attached to leads and placed into a “pocket” under the skin near the clavicle Pulse generator sends signal down leads in programmed sequence to contract atria, then ventricles Pulse generator can sense electrical activity generated by the heart and only deliver electrical impulses when needed. Pacemakers can only speed up a heart experiencing bradycardia, they cannot alter a condition of tachycardia
Slide 25-

Implantation of Pacemaker